• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩散模型可实现对阿尔茨海默病的定量脑血流量分析。

Diffusion model enables quantitative CBF analysis of Alzheimer's Disease.

作者信息

Shou Qinyang, Cen Steven, Chen Nan-Kuei, Ringman John M, Wen Junhao, Kim Hosung, Wang Danny Jj

机构信息

Laboratory of Functional MRI Technology (LOFT), Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, United States.

Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.

出版信息

medRxiv. 2024 Jul 3:2024.07.01.24309791. doi: 10.1101/2024.07.01.24309791.

DOI:10.1101/2024.07.01.24309791
PMID:39006427
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11245071/
Abstract

OBJECTIVES

Cerebral blood flow (CBF) measured by arterial spin labeling (ASL) is a promising biomarker for Alzheimer's Disease (AD). ASL data from multiple vendors were included in the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. However, the M0 images were missing in Siemens ASL data, prohibiting CBF quantification. Here, we utilized a generative diffusion model to impute the missing M0 and validated generated CBF data with acquired data from GE.

METHODS

A conditional latent diffusion model was trained to generate the M0 image and validate it on an in-house dataset (=55) based on image similarity metrics, accuracy of CBF quantification, and consistency with the physical model. This model was then applied to the ADNI dataset (Siemens: =211) to impute the missing M0 for CBF calculation. We further compared the imputed data (Siemens) and acquired data (GE) regarding regional CBF differences by AD stages, their classification accuracy for AD prediction, and CBF trajectory slopes estimated by a mixed effect model.

RESULTS

The trained diffusion model generated the M0 image with high fidelity (Structural similarity index, SSIM=0.924±0.019; peak signal-to-noise ratio, PSNR=33.348±1.831) and caused minimal bias in CBF values (mean difference in whole brain is 1.07±2.12ml/100g/min). Both generated and acquired CBF data showed similar differentiation patterns by AD stages, similar classification performance, and decreasing slopes with AD progression in specific AD-related regions. Generated CBF data also improved accuracy in classifying AD stages compared to qualitative perfusion data.

INTERPRETATION/CONCLUSION: This study shows the potential of diffusion models for imputing missing modalities for large-scale studies of CBF variation with AD.

摘要

目的

通过动脉自旋标记(ASL)测量的脑血流量(CBF)是阿尔茨海默病(AD)一种很有前景的生物标志物。来自多个供应商的ASL数据被纳入阿尔茨海默病神经影像倡议(ADNI)数据集。然而,西门子ASL数据中缺少M0图像,这使得无法进行CBF定量分析。在此,我们利用生成扩散模型来估算缺失的M0,并使用通用电气公司采集的数据对生成的CBF数据进行验证。

方法

训练一个条件潜在扩散模型来生成M0图像,并基于图像相似性指标、CBF定量分析的准确性以及与物理模型的一致性,在一个内部数据集(n = 55)上对其进行验证。然后将该模型应用于ADNI数据集(西门子:n = 211),以估算缺失的M0用于CBF计算。我们进一步比较了估算数据(西门子)和采集数据(通用电气)在AD分期方面的区域CBF差异、它们对AD预测的分类准确性以及通过混合效应模型估计的CBF轨迹斜率。

结果

训练后的扩散模型生成的M0图像具有高保真度(结构相似性指数,SSIM = 0.924±0.019;峰值信噪比,PSNR = 33.348±1.831),并且在CBF值上产生的偏差最小(全脑平均差异为1.07±2.12ml/100g/min)。生成的和采集的CBF数据在AD分期方面均显示出相似的分化模式、相似的分类性能,并且在特定的AD相关区域中随着AD进展斜率下降。与定性灌注数据相比,生成的CBF数据在AD分期分类方面也提高了准确性。

解读/结论:本研究显示了扩散模型在为CBF随AD变化的大规模研究估算缺失模态方面所具有的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/8e381105c852/nihpp-2024.07.01.24309791v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/236b12271fd9/nihpp-2024.07.01.24309791v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/59c0efd428d2/nihpp-2024.07.01.24309791v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/f0f09c919f0e/nihpp-2024.07.01.24309791v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/4002ebaf5ad7/nihpp-2024.07.01.24309791v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/0f7c556b0863/nihpp-2024.07.01.24309791v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/8e381105c852/nihpp-2024.07.01.24309791v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/236b12271fd9/nihpp-2024.07.01.24309791v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/59c0efd428d2/nihpp-2024.07.01.24309791v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/f0f09c919f0e/nihpp-2024.07.01.24309791v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/4002ebaf5ad7/nihpp-2024.07.01.24309791v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/0f7c556b0863/nihpp-2024.07.01.24309791v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c31/11245071/8e381105c852/nihpp-2024.07.01.24309791v1-f0006.jpg

相似文献

1
Diffusion model enables quantitative CBF analysis of Alzheimer's Disease.扩散模型可实现对阿尔茨海默病的定量脑血流量分析。
medRxiv. 2024 Jul 3:2024.07.01.24309791. doi: 10.1101/2024.07.01.24309791.
2
Improving Sensitivity of Arterial Spin Labeling Perfusion MRI in Alzheimer's Disease Using Transfer Learning of Deep Learning-Based ASL Denoising.利用深度学习 ASL 去噪的迁移学习提高阿尔茨海默病动脉自旋标记灌注 MRI 的灵敏度。
J Magn Reson Imaging. 2022 Jun;55(6):1710-1722. doi: 10.1002/jmri.27984. Epub 2021 Nov 6.
3
Potential Diagnostic Applications of Multi-Delay Arterial Spin Labeling in Early Alzheimer's Disease: The Chinese Imaging, Biomarkers, and Lifestyle Study.多延迟动脉自旋标记在早期阿尔茨海默病中的潜在诊断应用:中国影像学、生物标志物与生活方式研究
Front Neurosci. 2022 Jul 22;16:934471. doi: 10.3389/fnins.2022.934471. eCollection 2022.
4
The correlation between changes in gray matter microstructure and cerebral blood flow in Alzheimer's disease.阿尔茨海默病中灰质微观结构变化与脑血流量之间的相关性。
Front Aging Neurosci. 2023 Jun 2;15:1205838. doi: 10.3389/fnagi.2023.1205838. eCollection 2023.
5
Quantitative transport mapping of multi-delay arterial spin labeling MRI detects early blood perfusion alterations in Alzheimer's disease.多延迟动脉自旋标记 MRI 的定量转运图检测阿尔茨海默病的早期血流灌注改变。
Alzheimers Res Ther. 2024 Jul 8;16(1):156. doi: 10.1186/s13195-024-01524-6.
6
Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.动脉自旋标记 MRI 识别正常衰老及阿尔茨海默病连续体中的纵向脑血流变化。
J Alzheimers Dis. 2021;81(4):1727-1735. doi: 10.3233/JAD-210116.
7
Effects of the Fasting-Postprandial State on Arterial Spin Labeling MRI-Based Cerebral Perfusion Quantification in Alzheimer's Disease.禁食-餐后状态对阿尔茨海默病基于动脉自旋标记 MRI 的脑灌注定量的影响。
J Magn Reson Imaging. 2024 Nov;60(5):2173-2183. doi: 10.1002/jmri.29348. Epub 2024 Mar 27.
8
Optimized Convolutional Fusion for Multimodal Neuroimaging in Alzheimer's Disease Diagnosis: Enhancing Data Integration and Feature Extraction.用于阿尔茨海默病诊断的多模态神经成像优化卷积融合:增强数据整合与特征提取
J Pers Med. 2023 Oct 14;13(10):1496. doi: 10.3390/jpm13101496.
9
Cerebral perfusion in the predementia stages of Alzheimer's disease.阿尔茨海默病痴呆前期的脑灌注
Eur Radiol. 2016 Feb;26(2):506-14. doi: 10.1007/s00330-015-3834-9. Epub 2015 Jun 5.
10
Classifying cognitive impairment based on the spatial heterogeneity of cerebral blood flow images.基于脑血流图像空间异质性对认知障碍进行分类。
J Magn Reson Imaging. 2019 Sep;50(3):858-867. doi: 10.1002/jmri.26650. Epub 2019 Jan 21.

本文引用的文献

1
Disease staging of Alzheimer's disease using a CSF-based biomarker model.采用基于脑脊液生物标志物模型对阿尔茨海默病进行疾病分期。
Nat Aging. 2024 May;4(5):694-708. doi: 10.1038/s43587-024-00599-y. Epub 2024 Mar 21.
2
Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants.阿尔茨海默病的生物标志物:在早期和鉴别诊断以及识别非典型变异中的作用。
Alzheimers Res Ther. 2023 Oct 13;15(1):175. doi: 10.1186/s13195-023-01314-6.
3
Diffusion models in medical imaging: A comprehensive survey.扩散模型在医学成像中的应用:全面综述。
Med Image Anal. 2023 Aug;88:102846. doi: 10.1016/j.media.2023.102846. Epub 2023 May 23.
4
Altered cerebral blood flow in older adults with Alzheimer's disease: a systematic review.阿尔茨海默病老年患者脑血流改变:系统评价。
Brain Imaging Behav. 2023 Apr;17(2):223-256. doi: 10.1007/s11682-022-00750-6. Epub 2022 Dec 9.
5
Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.脑血流预测轻度认知障碍向阿尔茨海默病及认知衰退的转化:一项动脉自旋标记随访研究。
J Alzheimers Dis. 2021;82(1):293-305. doi: 10.3233/JAD-210199.
6
Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease.在一组有小血管疾病风险的老年拉丁裔受试者中,评估通过三维相位对比动脉自旋标记(3D PCASL)测量的脑血流量作为血管性认知障碍和痴呆(VCID)生物标志物的情况。
Front Neurosci. 2021 Jan 27;15:627627. doi: 10.3389/fnins.2021.627627. eCollection 2021.
7
Convolutional neural networks for classification of Alzheimer's disease: Overview and reproducible evaluation.卷积神经网络在阿尔茨海默病分类中的应用:综述与可重现性评估。
Med Image Anal. 2020 Jul;63:101694. doi: 10.1016/j.media.2020.101694. Epub 2020 May 1.
8
Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies.阿尔茨海默病的生物标志物——为疾病修饰疗法的新时代做准备。
Mol Psychiatry. 2021 Jan;26(1):296-308. doi: 10.1038/s41380-020-0721-9. Epub 2020 Apr 6.
9
Deep learning in biomedicine.深度学习在生物医学中的应用。
Nat Biotechnol. 2018 Oct;36(9):829-838. doi: 10.1038/nbt.4233. Epub 2018 Sep 6.
10
Deep Learning and Its Applications in Biomedicine.深度学习及其在生物医学中的应用。
Genomics Proteomics Bioinformatics. 2018 Feb;16(1):17-32. doi: 10.1016/j.gpb.2017.07.003. Epub 2018 Mar 6.